title: Behavioral effects of amphetamine in streptozotocin-treated rats.
abstract: Experimentally-induced diabetes can modify the behavioral and neurochemical effects of drugs acting on dopamine systems, possibly through insulin-related regulation of dopamine transporter activity. In this study, several behavioral procedures were used to examine possible changes in sensitivity to amphetamine and other drugs in rats rendered diabetic by a single injection of streptozotocin. Conditioned place preference developed to food (Froot Loops) in both control and diabetic rats, demonstrating that conditioned place preference with tactile stimuli can occur in streptozotocin-treated rats. Baseline locomotion was lower in streptozotocin-treated as compared to control rats, although amphetamine significantly increased locomotion in all rats. Conditioned place preference developed to amphetamine regardless of whether rats had received streptozotocin or saline. A second study compared the potency of drugs to decrease lever pressing maintained by food, before and after streptozotocin treatment. Gamma-hydroxybutyrate and amphetamine were less potent after streptozotocin while the potency of raclopride, quinpirole, ketamine, haloperidol and cocaine was not significantly changed by streptozotocin. While markedly affecting locomotion, body weight and blood glucose, streptozotocin only modestly affected sensitivity to the behavioral effects of amphetamine and other drugs; these results fail to confirm previous reports of decreased behavioral actions of stimulants in diabetic rats.
authors.affiliation: Department of Pharmacology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, United States.
authors.forename: Rajkumar J
authors.initials: RJ
authors.lastname: Sevak
authors.forename: Wouter
authors.initials: W
authors.lastname: Koek
authors.forename: Lynette C
authors.initials: LC
authors.lastname: Daws
authors.forename: William Anthony
authors.initials: WA
authors.lastname: Owens
authors.forename: Aurelio
authors.initials: A
authors.lastname: Galli
authors.forename: Charles P
authors.initials: CP
authors.lastname: France
mesh_terms: D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D003213:Conditioning, Psychological / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000523:psychology*; D004298:Dopamine / Q000502:physiology; D050483:Dopamine Plasma Membrane Transport Proteins / Q000502:physiology; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin
chemical_list: D001786:Blood Glucose; D050483:Dopamine Plasma Membrane Transport Proteins; D013311:Streptozocin; D000661:Amphetamine; D004298:Dopamine